- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Volume 2012 (2012), Article ID 796389, 8 pages
Streptococcal Pharyngitis: A Prospective Study of Compliance and Complications
1Pediatric and Adolescent Ambulatory Community Clinics-Clalit Health Care Services, 128 Alozorov Street, Tel-Aviv, Israel
2IPROS Network of the Israel Ambulatory Pediatrics Association, Israel Ambulatory Pediatric Association, Tel-Aviv, Israel
3Department of Family Practice, Clalit Health Services HMO, Sharon-Shomron District and Department of Family Practice, Tel-Aviv University, Tel-Aviv, Israel
Received 1 April 2012; Accepted 28 April 2012
Academic Editors: J. A. O'Neill and N. A. Shorter
Copyright © 2012 E. Michael Sarrell and Shmuel M. Giveon. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- P. S. Little and I. Williamson, “Are antibiotics appropriate for sore throats? Costs outweigh the benefits,” British Medical Journal, vol. 309, no. 6960, pp. 1010–1011, 1994.
- M. E. Pichichero, “Group A streptococcal tonsillopharyngitis: cost-effective diagnosis and treatment,” Annals of Emergency Medicine, vol. 25, no. 3, pp. 390–403, 1995.
- M. H. Lin, W. K. Fong, P. F. Chang, C. W. Yen, K. L. Hung, and S. J. Lin, “Predictive value of clinical features in differentiating group A βhemolytic streptococcal pharyngitis in children,” Journal of Microbiology, Immunology and Infection, vol. 36, no. 1, pp. 21–25, 2003.
- K. L. O'Brien, B. Schwartz, R. Facklam, et al., “Population based active surveillance for invasive group A Streptococcus,” in Program and Abstract of the 37th International Conference on Antimicrobial Agents and Chemotherapeutics, p. 356, American Society for Microbiology, Toronto, Canada, September 1997.
- M. E. Pichichero, “Group A beta-hemolytic streptococcal infections,” American Academy of Pediatrics, vol. 19, no. 9, pp. 291–302, 1998.
- K. A. Robertson, J. A. Volmink, and B. M. Mayosi, “Antibiotics for the primary prevention of acute rheumatic fever: a meta-analysis,” BMC Cardiovascular Disorders, vol. 5, article 11, 2005.
- C. B. Del Mar, P. P. Glasziou, and A. B. Spinks, “Antibiotics for sore throat,” Cochrane Database of Systematic Reviews, no. 4, Article ID CD000023, 2006.
- C. B. Del Mar, P. P. Glasziou, A. B. Spinks, W. R. Saliba, and R. Mader, “Antibiotics for sore throat,” Israel Medical Association Journal, vol. 2, no. 6, pp. 433–437, 2000.
- K. L. O'Brien, B. Schwartz, R. Facklam, et al., “Population based active surveillance for invasive group A Streptococcus,” in Proceedings of the 37th International Conference on Antimicrobial Agents and Chemotherapeutics, Program and Abstract, Toronto, Canada, September 1997, in Cochrane Database of Systematic Reviews, vol, 2, article CD000023, 2000.
- C. Olivier, “Rheumatic fever—is it still a problem?” Journal of Antimicrobial Chemotherapy, vol. 45, no. 1, pp. 13–21, 2000.
- G. S. Habib, Rheumatic Fever in the Nazareth Area During the Last Decade, American Society for Microbiology, Washington, DC, USA, 1997.
- P. Bidet, C. Plainvert, C. Doit et al., “Streptococcus pyogenes or groupA streptococcal infections in child: french national reference center data,” Archives de Pediatrie, vol. 17, no. 2, pp. 201–208, 2010.
- U. B. Schaad, “Acute streptococcal tonsillopharyngitis: a review of clinical efficacy and bacteriological eradication,” Journal of International Medical Research, vol. 32, no. 1, pp. 1–13, 2004.
- A. L. Bisano, M. A. Gerber, J. M. Gwalenty Jr., E. L. Kaplan, and R. H. Schwartz, “Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Infectious Disease Society of America,” Clinical Infectious Diseases, vol. 35, pp. 113–125, 2002.
- M. R. Jacobs, “Antimicrobial-resistant Streptococcus pneumoniae: trends and management,” Expert Review of Anti-Infective Therapy, vol. 6, no. 5, pp. 619–635, 2008.
- C. Llor, N. Sierra, S. Hernández et al., “Compliance rate of antibiotic therapy in patients with acute pharyngitis is very low, mainly when thrice-daily antibiotics are given,” Revista Espanola de Quimioterapia, vol. 22, no. 1, pp. 20–24, 2009 (Spanish).
- M. W. Attia, T. Zaoutis, J. D. Klein, and F. A. Meier, “Performance of a predictive model for streptococcal pharyngitis in children,” Archives of Pediatrics and Adolescent Medicine, vol. 155, no. 6, pp. 687–691, 2001.
- B. B. Breese, “A simple scorecard for the tentative diagnosis of streptococcal pharyngitis,” American Journal of Diseases of Children, vol. 131, no. 5, pp. 514–517, 1977.
- S. Nandi, R. Kumar, P. Ray, H. Vohra, and N. K. Ganguly, “Clinical score card for diagnosis of group A streptococcal sore throat,” Indian Journal of Pediatrics, vol. 69, no. 6, pp. 471–475, 2002.
- C. Hofer, H. J. Binns, and R. R. Tanz, “Strategies for managing group A streptococcal pharyngitis: a survey of board-certified pediatricians,” Archives of Pediatrics and Adolescent Medicine, vol. 151, no. 8, pp. 824–829, 1997.
- R. A. Rennie, “Prospective study of antibiotic prescribed for children,” Canadian Family Physician, vol. 44, pp. 1850–1856, 1998.
- R. M. Centor, “Expand the pharyngitis paradigm for adolescents and young adults,” Annals of Internal Medicine, vol. 151, no. 11, pp. 812–815, 2009.
- S. Vinker, E. Zohar, R. Hoffman, and A. Elhayany, “Incidence and clinical manifestations of rheumatic fever: a 6 year community-Based survey,” Israel Medical Association Journal, vol. 12, no. 2, pp. 78–81, 2010.
- M. E. Pichichero, J. R. Casey, T. Mayes et al., “Penicillin failure in streptococcal tonsillopharyngitis: causes and remedies,” Pediatric Infectious Disease Journal, vol. 19, no. 9, pp. 917–923, 2000.
- D. A. Kafetzis, G. Liapi, M. Tsolia et al., “Failure to eradicate Group A β-haemolytic streptococci (GABHS) from the upper respiratory tract after antibiotic treatment,” International Journal of Antimicrobial Agents, vol. 23, no. 1, pp. 67–71, 2004.
- M. E. Pichichero, J. L. Green, A. B. Francis et al., “Recurrent group A streptococcal tonsillopharyngitis,” Pediatric Infectious Disease Journal, vol. 17, no. 9, pp. 809–815, 1998.
- M. A. Gerber, R. R. Tanz, W. Kabat et al., “Potential mechanisms for failure to eradicate group A streptococci from the pharynx,” Pediatrics, vol. 104, no. 4 I, pp. 911–917, 1999.
- J. Liñares, C. Ardanuy, R. Pallares, and A. Fenoll, “Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period,” Clinical Microbiology and Infection, vol. 16, no. 5, pp. 402–410, 2010.
- L. F. McCaig, R. E. Besser, and J. M. Hughes, “Trends in antimicrobial prescribing rates for children and adolescents,” Journal of the American Medical Association, vol. 287, no. 23, pp. 3096–3102, 2002.
- D. Adam, H. Scholz, and M. Helmerking, “Short-course antibiotic treatment of 4782 culture-proven cases of group A streptococcal tonsillopharyngitis and incidence of poststreptococcal sequelae,” Journal of Infectious Diseases, vol. 182, no. 2, pp. 509–516, 2000.
- T. Koga, T. Rikimaru, N. Tokunaga et al., “Evaluation of short-term clinical efficacy of 3-day therapy with azithromycin in comparison with 5-day cefcapene-pivoxyl for acute streptococcal tonsillopharyngitis in primary care,” Journal of Infection and Chemotherapy, vol. 17, no. 4, pp. 499–503, 2011.